Tympanogen
PrivateLast Round
Series A
Mar 13, 2025
Total Funding Raised
$7.47M
Company Overview
Tympanogen is a medical device company that develops innovative, nonsurgical solutions for ear, nose, and throat (ENT) conditions, including its flagship Perf-Fix™ gel patch for eardrum repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tympanogen Comparables
Compare Tympanogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TymCure Ltd. | 81% | |
| Innovia Medical | 80% | |
| Tympulse Medical | 78% | |
Tympanogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 13, 2025 | ||||
| Grant | Jul 25, 2023 | ||||
| Debt | Mar 1, 2022 | ||||
| Grant | Nov 1, 2021 | ||||
| Grant | Jun 17, 2020 | ||||
Grant | Jan 7, 2020 |
Tympanogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| ShockVentures | Debt |
| CAV Angels | Series A, Debt |
| Virginia Innovation Partnership Corporation | VC Round |
| Virginia Venture Partners | Debt |
| Keiretsu Forum Mid-Atlantic | Series A, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
$1.48M round led by Keiretsu Forum Mid-Atlantic.
- Jul 25, 2023
$3.23M grant from NIDCD and NIH RADx.
Tympanogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tympanogen's valuation, stock price, and market status.